Eskayef Pharmaceutical Limited (SK+F)
Eskayef Pharmaceutical Limited (SK+F), a successor of world-renowned multinational pharmaceutical company, SmithKline & French (SK&F), USA was acquired by TRANSCOM in 1990 in the wake of the merger between SmithKline & French, USA and Beecham, UK.
TRANSCOM is one of the leading and fastest growing business conglomerates in Bangladesh. Like TRANSCOM, not many industrial groups in Bangladesh can claim a history of continuous business pursuits stretching back over 100 years. Over the time, its early industrial ventures have moved over to businesses involved in high-tech manufacturing, international trading and distribution, forming strong ties with a host of blue chip multinational companies. After the acquisition of SK&F by TRANSCOM, the new company was named –Eskayef Pharmaceutical Limited and it has subsequently culminated to become one of the leading pharmaceutical companies of Bangladesh. Rapid business growth since its inception have propelled Eskayef to a position of eminence among the pharmaceutical companies operating in Bangladesh today.